This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kajantie, E. Articles by Andersson, S. Search for Related Content PubMed PubMed Citation Articles by Kajantie, E. Articles by Andersson, S.

IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants

Hospital for Children and Adolescents (E.K., L.D., A.S., S.A.), Helsinki University Central Hospital, 00029 HUS, Helsinki, Finland; and Department of Obstetrics and Gynecology (E.-M.R., M.S., R.K., S.A.), Helsinki University Central Hospital, 00029 HUS, Helsinki, Finland

Address all correspondence and requests for reprints to: Eero Kajantie, M.D., Hospital for Children and Adolescents, Helsinki University Central Hospital, PL 280, 00029 HUS, Finland. E-mail: . eero.kajantie{at}hus.fi

Abstract

Impaired postnatal growth in very low birth weight (VLBW, <1500 g) infants is per se a major clinical challenge and may also serve as a model in studying the mechanisms of growth retardation in general. This study was undertaken to characterize the role of IGFs and their binding proteins (IGFBPs), key regulators of fetal and infant growth, during the postnatal period in VLBW infants.

Forty-eight VLBW infants (gestational age 27.6 ± 2.2 wk, birth weight 923 ± 257 g) were studied. Blood samples were drawn at 1, 2, 4, and 8 wk of age for measurements of IGF-I, IGFBP-1 (lesser phosphorylated, lpIGFBP-1, and highly phosphorylated, hpIGFBP-1), IGFBP-3, and insulin, simultaneous growth velocities being assessed by a rigorous protocol of repeated, frequent lower leg length and body weight measurements. All regression analyses were adjusted for postnatal age and repeated measurements.

Lower leg growth velocity showed a positive correlation with IGF-I (P = 0.01) and IGFBP-3 (P = 0.03), and weight growth velocity with IGFBP-3 (P = 0.057) and with lpIGFBP-1/hpIGFBP-1 ratio (P = 0.01). Moreover, concurrent glucocorticoid dose showed a negative correlation with both IGFBP-1 isoforms, observable, however, only in samples with high (>10 U/liter) insulin (lpIGFBP-1, P = 0.02; hpIGFBP-1, P = 0.007). In backward multiple regression analysis, the factor remaining significantly associated with lower leg growth velocity (R² = 0.63) was IGF-I, and factors associated with weight growth velocity (R² = 0.81) were IGFBP-3 and the lpIGFBP-1/hpIGFBP-1 ratio.

In conclusion, circulating IGF-I and IGFBP-3, and the lpIGFBP-1/hpIGFBP-1 ratio, reflect short-term growth velocity in VLBW infants. lpIGFBP-1 isoforms, abundant in the circulation of these infants, may thus also have properties that are at least less inhibitory, if not promoting, on the growth-stimulating action of IGF-I. Finally, the regulation of IGFBP-1 by glucocorticoids may be divergent in situations with a high or low insulin concentration.

This article has been cited by other articles:

				M. Nissum, M. Abu Shehab, U. Sukop, J. M. Khosravi, R. Wildgruber, C. Eckerskorn, V. K. M. Han, and M. B. Gupta Functional and Complementary Phosphorylation State Attributes of Human Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) Isoforms Resolved by Free Flow Electrophoresis Mol. Cell. Proteomics, June 1, 2009; 8(6): 1424 - 1435. [Abstract] [Full Text] [PDF]

				T. C. R. Prickett, B. Dixon, C. Frampton, T. G. Yandle, A. M. Richards, E. A. Espiner, and B. A. Darlow Plasma Amino-Terminal Pro C-Type Natriuretic Peptide in the Neonate: Relation to Gestational Age and Postnatal Linear Growth J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 225 - 232. [Abstract] [Full Text] [PDF]

				F. Schreiner, S. Stutte, P. Bartmann, B. Gohlke, and J. Woelfle Association of the Growth Hormone Receptor d3-Variant and Catch-up Growth of Preterm Infants with Birth Weight of Less Than 1500 Grams J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4489 - 4493. [Abstract] [Full Text] [PDF]

				E. S. Buhl, S. Neschen, S. Yonemitsu, J. Rossbacher, D. Zhang, K. Morino, A. Flyvbjerg, P. Perret, V. Samuel, J. Kim, et al. Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1451 - E1458. [Abstract] [Full Text] [PDF]

				M. E Street, P. Seghini, S. Fieni, M. A. Ziveri, C. Volta, D. Martorana, I. Viani, D. Gramellini, and S. Bernasconi Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur. J. Endocrinol., October 1, 2006; 155(4): 567 - 574. [Abstract] [Full Text] [PDF]

				R. A. Bazaes, A. Alegria, E. Pittaluga, A. Avila, G. Iniguez, and V. Mericq Determinants of Insulin Sensitivity and Secretion in Very-Low-Birth-Weight Children J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1267 - 1272. [Abstract] [Full Text] [PDF]

				I. El Khattabi, F. Gregoire, C. Remacle, and B. Reusens Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E991 - E1000. [Abstract] [Full Text] [PDF]